Cargando…

Optimizing Multidisciplinary Care of Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus

Diabetes is the leading cause of chronic kidney disease (CKD), a condition associated with significant morbidity and mortality. As these patients have a high risk of developing cardiovascular disease and end-stage kidney disease, there is a need for early detection and early initiation of appropriat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kelepouris, Ellie, St. Peter, Wendy, Neumiller, Joshua J., Wright, Eugene E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241769/ https://www.ncbi.nlm.nih.gov/pubmed/37209236 http://dx.doi.org/10.1007/s13300-023-01416-2

Ejemplares similares

Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
por: Holland, Daniel Q, et al.
Publicado: (2014)

Mechanisms and clinical applications of incretin therapies for diabetes and chronic kidney disease
por: Alicic, Radica Z., et al.
Publicado: (2023)

Management of Hyperglycemia in Diabetic Kidney Disease
por: Neumiller, Joshua J., et al.
Publicado: (2015)

Living with Chronic Kidney Disease and Type 2 Diabetes Mellitus: The Patient and Clinician Perspective
por: Nicholas, Susanne B., et al.
Publicado: (2022)

Perspectives on optimizing care of patients in multidisciplinary chronic kidney disease clinics
por: Collister, David, et al.
Publicado: (2016)

Efficacy and Safety of Saxagliptin as Add-On Therapy in Type 2 Diabetes
por: Neumiller, Joshua J.
Publicado: (2014)

2018 Standards of Care Update: Pharmacologic Approaches to Glycemic Management in People With Type 2 Diabetes
por: Neumiller, Joshua J., et al.
Publicado: (2018)

Perspectives on Chronic Kidney Disease With Type 2 Diabetes and Risk Management: Practical Viewpoints and a Paradigm Shift Using a Pillar Approach
por: Morales, Javier, et al.
Publicado: (2023)

Empagliflozin: a new sodium-glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes
por: Neumiller, Joshua J
Publicado: (2014)

Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)
por: de Boer, Ian H., et al.
Publicado: (2022)

Managed Care to Medicare: Sharing the Burden of Chronic Kidney Disease
por: Peter, Wendy St.
Publicado: (2007)

What is the value of multidisciplinary care for chronic kidney disease?
por: Fluck, Richard J., et al.
Publicado: (2018)

Diabetes Spectrum: Past, Present, and Future
por: Neumiller, Joshua J.
Publicado: (2018)

Management of type 2 diabetes mellitus in the elderly: role of the pharmacist in a multidisciplinary health care team
por: Grossman, Samuel
Publicado: (2011)

Multidisciplinary care for poor patients with chronic kidney disease in Mexico
por: Garcia-Garcia, Guillermo, et al.
Publicado: (2013)

Chronic Kidney Disease and Medicare
por: Peter, Wendy St.
Publicado: (2007)

Erratum. Sodium–Glucose Cotransporter 2 Inhibition and Diabetic Kidney Disease. Diabetes 2019;68:248–257
por: Alicic, Radica Z., et al.
Publicado: (2019)

Acute and chronic kidney complications in children with type 1 diabetes mellitus
por: Rivetti, Giulio, et al.
Publicado: (2022)

Prevalence of anemia in primary care patients with Type 2 diabetes mellitus and chronic kidney disease in Oman
por: Alsalmani, Asma A., et al.
Publicado: (2023)

Cost-effectiveness of multidisciplinary care in mild to moderate chronic kidney disease in the United States: A modeling study
por: Lin, Eugene, et al.
Publicado: (2018)

Insulin Resistance and Chronic Kidney Disease in Patients with Type 1 Diabetes Mellitus
por: Vladu, Mihaela, et al.
Publicado: (2017)

Chronic kidney disease in patients with diabetes mellitus
por: Nordheim, Espen, et al.
Publicado: (2021)

Cystic fibrosis-related diabetes: optimizing care with a multidisciplinary approach
por: Frost, Freddy, et al.
Publicado: (2019)

What should the optimal blood pressure goal be in patients with diabetes mellitus or chronic kidney disease?
por: Aronow, Wilbert S.
Publicado: (2012)

Effect of metformin on kidney function in patients with type 2 diabetes mellitus and moderate chronic kidney disease
por: Hsu, Wei-Hao, et al.
Publicado: (2017)

Pharmacology, efficacy and safety of liraglutide in the management of type 2 diabetes
por: Neumiller, Joshua J, et al.
Publicado: (2010)

Empagliflozin: Role in Treatment Options for Patients with Type 2 Diabetes Mellitus
por: Anderson, John E., et al.
Publicado: (2016)

Retinopathy and clinical outcomes in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia
por: Bello, Natalie A, et al.
Publicado: (2014)

Introduction: Chronic Kidney Disease: A Burgeoning Health Epidemic
por: Peter, Wendy St.
Publicado: (2007)

Adropin Predicts Chronic Kidney Disease in Type 2 Diabetes Mellitus Patients with Chronic Heart Failure
por: Berezina, Tetiana A., et al.
Publicado: (2023)

Descriptive study of the economic burden among patients with type 2 diabetes mellitus, chronic kidney disease, and chronic kidney disease and type 2 diabetes mellitus in a large US commercially insured population
por: Chung, Haechung, et al.
Publicado: (2023)

The role of diabetes mellitus and hypertension in chronic kidney disease
por: Ghaderian, Seyed Bahman, et al.
Publicado: (2014)

Management of diabetes mellitus in patients with chronic kidney disease
por: Hahr, Allison J., et al.
Publicado: (2015)

Prevalence of Diabetes Mellitus in Patients with Chronic Kidney Disease
por: Stojceva-Taneva, Olivera, et al.
Publicado: (2016)

Differences in NAFLD/NASH Management by Provider Specialty: Opportunities for Optimizing Multidisciplinary Care
por: Porayko, Michael K, et al.
Publicado: (2022)

Optimal Early Diagnosis and Monitoring of Diabetic Kidney Disease in Type 2 Diabetes Mellitus: Addressing the Barriers to Albuminuria Testing
por: Christofides, Elena A., et al.
Publicado: (2021)

Medulloblastoma: optimizing care with a multidisciplinary approach
por: Thomas, Alice, et al.
Publicado: (2019)

Optimal Obesity- and Lipid-Related Indices for Predicting Metabolic Syndrome in Chronic Kidney Disease Patients with and without Type 2 Diabetes Mellitus in China
por: Li, Hangtian, et al.
Publicado: (2022)

The Prevalence, Progress and Risk Factor Control of Chronic Kidney Disease in Chinese Adults With Type 2 Diabetes Mellitus in Primary Care
por: An, Lingwang, et al.
Publicado: (2022)

A 5-structured visits multidisciplinary clinical care approach to optimize the care of patients with type 2 diabetes: a pilot study
por: Allam, Magdy Mohamed, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5osgfitur9ucjstbkqf7339nt3